Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Cross-Linked Ionic Core Micelles for Efficient Delivery of Therapeutics

Novel micelles by creating amphiphilic block copolymers...

Mechanism of action

Drug Delivery

Full description

Summary
Micelles are often used for drug delivery; however, there is a need for improved compositions Researchers at The University of Nebraska Medical Center have developed novel micelles by creating amphiphilic block copolymers that have a large solubility difference between the hydrophilic and hydrophobic blocks that assemble in aqueous solutions into polymer micelles of nanoscale size. The micelles can be used to encapsulate drugs or biological agents for improved delivery of the therapeutic agent. The novel micelle composition combines several structural features which improve the micelle’s capacity for drug delivery as compared to existing polymer micelle drug delivery compositions.

Market Value
Use in hospitals world-wide for improvment of drug delivery. May be used widely in cancer research/treatment.


Features and Benefits

  • Improved Therapeutic Index
  • Increased Stability and Solubility
  • Wide Range of Deliverable Biological Agents
  • Increased Bioavailability
  • Permeable to Membranes and Biological Barriers

Development status

Early Stage

Patent information

Application Published (US-2004-228823-A1)

(TID - 28)

Type of business relationship sought

UNeMed Corporation offers a variety of licensing options and collaborative development opportunities with the University of Nebraska Medical Center.

Licensing contact

Dr. Jack Hartwigsen
Sr. Licensing Associate
Request more information

More information

For more information about the product please visit website.

Company details

University of Nebraska Medical Center / UNeMed Corporation
Technology Marketing and Licensing for The University of Nebraska Medical Center

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Industry sector
Drug delivery
Pharmaceutical
Therapeutic target
Other therapeutic
Partnering consultation free of charge
BioNetwork West 2008
Biotech Patents
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us